as 12-18-2024 12:45pm EST
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.
Founded: | 1998 | Country: | United States |
Employees: | N/A | City: | WILLIAMSVILLE |
Market Cap: | 3.9M | IPO Year: | N/A |
Target Price: | N/A | AVG Volume (30 days): | 9.7M |
Analyst Decision: | N/A | Number of Analysts: | N/A |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -1126.22 | EPS Growth: | N/A |
52 Week Low/High: | $3.90 - $581.85 | Next Earning Date: | 11-12-2024 |
Revenue: | $17,304,000 | Revenue Growth: | -9.52% |
Revenue Growth (this year): | 56.94% | Revenue Growth (next year): | 2.98% |
XXII Breaking Stock News: Dive into XXII Ticker-Specific Updates for Smart Investing
Newsfile
5 days ago
Newsfile
6 days ago
GuruFocus.com
a month ago
Newsfile
a month ago
Newsfile
a month ago
Newsfile
2 months ago
Newsfile
2 months ago
Newsfile
3 months ago
The information presented on this page, "XXII 22nd Century Group Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.